Co-Authors
This is a "connection" page, showing publications co-authored by AMAN U BUZDAR and SHARON HERMES GIORDANO.
Connection Strength
0.662
-
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol. 2010 Jan 01; 28(1):92-8.
Score: 0.088
-
Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol. 2008 Oct 20; 26(30):4891-8.
Score: 0.081
-
Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005 Dec 01; 104(11):2359-64.
Score: 0.067
-
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005 Jun 01; 23(16):3676-85.
Score: 0.064
-
Breast carcinoma in men. Cancer. 2005 Jan 15; 103(2):432-3; author reply 433.
Score: 0.063
-
Breast carcinoma in men: a population-based study. Cancer. 2004 Jul 01; 101(1):51-7.
Score: 0.061
-
Is breast cancer survival improving? Cancer. 2004 Jan 01; 100(1):44-52.
Score: 0.059
-
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer. Clin Cancer Res. 2002 Nov; 8(11):3360-8.
Score: 0.054
-
Breast cancer in men. Ann Intern Med. 2002 Oct 15; 137(8):678-87.
Score: 0.054
-
Efficacy of anastrozole in male breast cancer. Am J Clin Oncol. 2002 Jun; 25(3):235-7.
Score: 0.053
-
Trends for inflammatory breast cancer: is survival improving? Oncologist. 2007 Aug; 12(8):904-12.
Score: 0.019